News

Two additional Blue Cross Blue Shield (BCBS) plans are now covering Pulmonx’s Zephyr Endobronchial Valve and similar devices to treat severe emphysema, a form of chronic obstructive pulmonary disease (COPD). With the addition of these two plans to similar previous policy decisions, valves will be now covered for the…

Renovion is teaming up with the COPD Foundation to develop a new nebulized therapy that aims to help clear mucus and reduce inflammation in people with chronic obstructive pulmonary disease (COPD) and non-cystic fibrosis bronchiectasis. Phase 2 clinical trials of the investigational treatment, called  ARINA-1, are planned to…

Noninvasive ventilation at home, known as NIVH, can reduce the risk of hospitalization, emergency department visits, and death in people with chronic obstructive pulmonary disease (COPD) who have trouble getting enough oxygen, new research indicates. NIVH is a breathing support technique given at home, using a face or nasal…

A $12.8 million five-year renewal grant from the National Institutes of Health (NIH) will fund research that seeks to better understand the molecular mechanisms that drive chronic obstructive pulmonary disease (COPD) and other lung diseases. The research also aims to increase understanding of how cigarette smoking affects the development…

Twenty years after the collapse the World Trade Center, rescue workers and volunteers who assisted at the site in the two days that immediately followed face a 30% increased risk of chronic obstructive pulmonary disease (COPD), researchers report. COPD in these first responders is often preceded by a diagnosis of…

The health-related quality of life of people with chronic obstructive pulmonary disease (COPD) living in Barcelona, Spain, is negatively affected by exposure to air pollution and living farther away from green or blue water-rich spaces, a study suggests. “This study, performed for the first time on a Mediterranean population,…

Therapeutic Solutions International has filed a patent covering the therapeutic use of JadiCells — a type of mesenchymal stem cell derived from cells lining the umbilical cord — and its various combinations in treating chronic obstructive pulmonary disease (COPD). The patent application is supported by new data indicating…

Treatment with human mesenchymal stem cells (MSCs) results in a strong, but temporary, reduction in pro-inflammatory molecules involved in chronic obstructive pulmonary disease (COPD), according to data from a Phase 1 clinical trial involving nine COPD patients. Notably, molecules directly produced by MSCs were identified as potential drivers of these…

Kaleido Biosciences is teaming up with the COPD Foundation to investigate KB109, a small compound designed to modulate the gut microbiome — the community of microbes living in the intestines — as a potential treatment for chronic obstructive pulmonary disease (COPD). The decision was based on promising…

One hundred patients have been randomly assigned in Nuvaira’s pivotal AIRFLOW-3 clinical trial that will investigate the efficacy and safety of targeted lung denervation (TLD) to reduce exacerbations, or episodes of symptom worsening, of chronic obstructive pulmonary disease (COPD) in patients on optimal medical care. Because of the…